{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T11:54:24Z","timestamp":1725278064621},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,28]]},"DOI":"10.7759\/cureus.55192","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T06:56:00Z","timestamp":1709189760000},"source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Efficacy of Midodrine for Tapering Off Vasopressors"],"prefix":"10.7759","author":[{"given":"Zoraize Moeez","family":"Athar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnoor","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitij","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s004230050090","article-title":"Outcome of patients with sepsis and septic shock after ICU treatment","volume":"383","author":"Schoenberg MH","year":"1998","unstructured":"Schoenberg MH, Weiss M, Radermacher P. Outcome of patients with sepsis and septic shock after ICU treatment. Langenbecks Arch Surg. 1998, 383:44-8. 10.1007\/s004230050090","journal-title":"Langenbecks Arch Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.51893\/2022.4.R","article-title":"Midodrine use in critically ill patients: a narrative review","volume":"24","author":"Costa-Pinto R","year":"2022","unstructured":"Costa-Pinto R, Jones DA, Udy AA, Warrillow SJ, Bellomo R. Midodrine use in critically ill patients: a narrative review. Crit Care Resusc. 2022, 24:298-308. 10.51893\/2022.4.R","journal-title":"Crit Care Resusc"},{"key":"ref4","article-title":"AT 241435; Eidem, US Patent 3,340,298 (1965, 1967 Both to Chemie Linz Ag)","author":"Karl W","year":"1967","unstructured":"Karl W, Otto S, Rudolf K, Gerhard Z. AT 241435; Eidem, US Patent 3,340,298 (1965, 1967 Both to Chemie Linz Ag). 1967."},{"key":"ref5","article-title":"Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite","volume":"26","author":"Pittner H","year":"1976","unstructured":"Pittner H, Stormann H, Enzenhofer R. Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite. ST 1059. Arzneimittelforschung. 1976, 26:2145-54.","journal-title":"ST 1059. Arzneimittelforschung"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06216-x","article-title":"Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial","volume":"46","author":"Santer P","year":"2020","unstructured":"Santer P, Anstey MH, Patroc\u00ednio MD, et al.. Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial. Intensive Care Med. 2020, 46:1884-93. 10.1007\/s00134-020-06216-x","journal-title":"Intensive Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000382","article-title":"Oral midodrine administration during the first 24 hours of sepsis to reduce the need of vasoactive agents: placebo-controlled feasibility clinical trial","volume":"3","author":"Lal A","year":"2021","unstructured":"Lal A, Trivedi V, Rizvi MS, et al.. Oral midodrine administration during the first 24 hours of sepsis to reduce the need of vasoactive agents: placebo-controlled feasibility clinical trial. Crit Care Explor. 2021, 3:e0382. 10.1097\/CCE.0000000000000382","journal-title":"Crit Care Explor"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003121","article-title":"Trends in use of midodrine in the ICU: a single-center retrospective case series","volume":"46","author":"Rizvi MS","year":"2018","unstructured":"Rizvi MS, Trivedi V, Nasim F, Lin E, Kashyap R, Andrijasevic N, Gajic O. Trends in use of midodrine in the ICU: a single-center retrospective case series. Crit Care Med. 2018, 46:e628-33. 10.1097\/CCM.0000000000003121","journal-title":"Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2013.05.021","article-title":"Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions","volume":"28","author":"Levine AR","year":"2013","unstructured":"Levine AR, Meyer MJ, Bittner EA, et al.. Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions. J Crit Care. 2013, 28:756-62. 10.1016\/j.jcrc.2013.05.021","journal-title":"J Crit Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-021-02903-w","article-title":"Midodrine improves clinical and economic outcomes in patients with septic shock: a randomized controlled clinical trial","volume":"191","author":"Adly DH","year":"2022","unstructured":"Adly DH, Bazan NS, El Borolossy RM, Anan IF, Fakher MA, El Wakeel LM. Midodrine improves clinical and economic outcomes in patients with septic shock: a randomized controlled clinical trial. Ir J Med Sci. 2022, 191:2785-95. 10.1007\/s11845-021-02903-w","journal-title":"Ir J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2021.11.004","article-title":"A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: the MAVERIC study","volume":"67","author":"Costa-Pinto R","year":"2022","unstructured":"Costa-Pinto R, Yong ZT, Yanase F, et al.. A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: the MAVERIC study. J Crit Care. 2022, 67:166-71. 10.1016\/j.jcrc.2021.11.004","journal-title":"J Crit Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxac069","article-title":"Putting midodrine on the MAP: an approach to liberation from intravenous vasopressors in vasodilatory shock","volume":"79","author":"Smith SE","year":"2022","unstructured":"Smith SE, Peters NA, Floris LM, Patterson JM, Hawkins WA. Putting midodrine on the MAP: an approach to liberation from intravenous vasopressors in vasodilatory shock. Am J Health Syst Pharm. 2022, 79:1047-55. 10.1093\/ajhp\/zxac069","journal-title":"Am J Health Syst Pharm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X221105297","article-title":"Oral midodrine does not expedite liberation from protracted vasopressor infusions: a case-control study","volume":"51","author":"Wood AJ","year":"2023","unstructured":"Wood AJ, Rauniyar R, Jacques A, Palmer RN, Wibrow B, Anstey MH. Oral midodrine does not expedite liberation from protracted vasopressor infusions: a case-control study. Anaesth Intensive Care. 2023, 51:20-8. 10.1177\/0310057X221105297","journal-title":"Anaesth Intensive Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0885066619843279","article-title":"Midodrine as an adjuvant to intravenous vasopressor agents in adults with resolving shock: systematic review and meta-analysis","volume":"35","author":"Hammond DA","year":"2020","unstructured":"Hammond DA, Smith MN, Peksa GD, Trivedi AP, Balk RA, Menich BE. Midodrine as an adjuvant to intravenous vasopressor agents in adults with resolving shock: systematic review and meta-analysis. J Intensive Care Med. 2020, 35:1209-15. 10.1177\/0885066619843279","journal-title":"J Intensive Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-023-00301-0","article-title":"The use of midodrine as an adjunctive therapy to liberate patients from intravenous vasopressors: a systematic review and meta-analysis of randomized controlled studies","volume":"12","author":"Hamed M","year":"2023","unstructured":"Hamed M, Elseidy SA, Elkheshen A, et al.. The use of midodrine as an adjunctive therapy to liberate patients from intravenous vasopressors: a systematic review and meta-analysis of randomized controlled studies. Cardiol Ther. 2023, 12:185-95. 10.1007\/s40119-023-00301-0","journal-title":"Cardiol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12375","article-title":"Midodrine for the weaning of vasopressor infusions","volume":"41","author":"Poveromo LB","year":"2016","unstructured":"Poveromo LB, Michalets EL, Sutherland SE. Midodrine for the weaning of vasopressor infusions. J Clin Pharm Ther. 2016, 41:260-5. 10.1111\/jcpt.12375","journal-title":"J Clin Pharm Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.02.657","article-title":"Feasibility, utility, and safety of midodrine during recovery phase from septic shock","volume":"149","author":"Whitson MR","year":"2016","unstructured":"Whitson MR, Mo E, Nabi T, Healy L, Koenig S, Narasimhan M, Mayo PH. Feasibility, utility, and safety of midodrine during recovery phase from septic shock. Chest. 2016, 149:1380-3. 10.1016\/j.chest.2016.02.657","journal-title":"Chest"},{"key":"ref18","article-title":"Midodrine as adjunction support for weaning off norepinephrine in septic shock","volume":"116","author":"Hafez HGM","year":"2023","unstructured":"Hafez HGM, Nashed SW, Morkos FAAEM, Abd El Wahab WAEM. Midodrine as adjunction support for weaning off norepinephrine in septic shock. QJM-Int J Med. 2023, 116:hcad069.045.","journal-title":"QJM-Int J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202305_32331","article-title":"Effect of midodrine on the prognosis of patients with septic shock: a systematic review and meta-analysis","volume":"27","author":"He QF","year":"2023","unstructured":"He QF, Xing XK, Wang TQ, Jiang ZX, Zhang G. Effect of midodrine on the prognosis of patients with septic shock: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2023, 27:4211-20. 10.26355\/eurrev_202305_32331","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06115-0","article-title":"LIBERATE: a study protocol for midodrine for the early liberation from vasopressor support in the intensive care unit (LIBERATE): protocol for a randomized controlled trial","volume":"23","author":"Opgenorth D","year":"2022","unstructured":"Opgenorth D, Baig N, Fiest K, et al.. LIBERATE: a study protocol for midodrine for the early liberation from vasopressor support in the intensive care unit (LIBERATE): protocol for a randomized controlled trial. Trials. 2022, 23:194. 10.1186\/s13063-022-06115-0","journal-title":"Trials"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/235359-exploring-the-efficacy-of-midodrine-for-tapering-off-vasopressors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T06:56:05Z","timestamp":1709189765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/235359-exploring-the-efficacy-of-midodrine-for-tapering-off-vasopressors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.55192","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,28]]}}}